-
1
CX-5461 can destabilize replication forks in PARP inhibitor-resistant models of ovarian cancer
Published 2020-11-01Subjects: Get full text
Article -
2
Ribosomal Dysregulation in Metastatic Laryngeal Squamous Cell Carcinoma: Proteomic Insights and CX-5461’s Therapeutic Promise
Published 2024-05-01Subjects: Get full text
Article -
3
Effects of the G-quadruplex-binding drugs quarfloxin and CX-5461 on the malaria parasite Plasmodium falciparum
Published 2023-12-01Subjects: Get full text
Article -
4
RNA polymerase I inhibition induces terminal differentiation, growth arrest, and vulnerability to senolytics in colorectal cancer cells
Published 2022-08-01Subjects: Get full text
Article -
5
Transcription-associated topoisomerase 2α (TOP2A) activity is a major effector of cytotoxicity induced by G-quadruplex ligands
Published 2021-06-01Subjects: Get full text
Article -
6
Targeting the RNA Polymerase I Transcription for Cancer Therapy Comes of Age
Published 2020-01-01Subjects: Get full text
Article -
7
NF45/NF90‐mediated rDNA transcription provides a novel target for immunosuppressant development
Published 2021-02-01Subjects: “…CX5461…”
Get full text
Article -
8
A G-quadruplex stabilizer, CX-5461 combined with two immune checkpoint inhibitors enhances in vivo therapeutic efficacy by increasing PD-L1 expression in colorectal cancer
Published 2023-01-01Subjects: “…CX-5461…”
Get full text
Article -
9
Plant exosomes fused with engineered mesenchymal stem cell‐derived nanovesicles for synergistic therapy of autoimmune skin disorders
Published 2023-10-01Subjects: Get full text
Article -
10
Targeting RNA Polymerase I Transcription Activity in Osteosarcoma: Pre-Clinical Molecular and Animal Treatment Studies
Published 2023-04-01Subjects: Get full text
Article -
11
CX-5461 is a potent immunosuppressant which inhibits T cell-mediated alloimmunity via p53-DUSP5
Published 2022-03-01Subjects: Get full text
Article -
12
Molecular basis of CX-5461-induced DNA damage response in primary vascular smooth muscle cells
Published 2024-09-01Subjects: “…CX-5461…”
Get full text
Article -
13
A transcriptional program associated with cell cycle regulation predominates in the anti-inflammatory effects of CX-5461 in macrophage
Published 2022-10-01Subjects: Get full text
Article -
14
Oral administration of Sophora Flavescens-derived exosomes-like nanovesicles carrying CX5461 ameliorates DSS-induced colitis in mice
Published 2024-10-01Subjects: Get full text
Article -
15
Alternative splicing of human telomerase reverse transcriptase in gliomas and its modulation mediated by CX-5461
Published 2018-04-01Subjects: Get full text
Article -
16
Targeting the ribosome to treat multiple myeloma
Published 2024-03-01Subjects: Get full text
Article -
17
-
18
rDNA Chromatin Activity Status as a Biomarker of Sensitivity to the RNA Polymerase I Transcription Inhibitor CX-5461
Published 2020-07-01Subjects: Get full text
Article